乳糜泻与肠易激综合征的关联:全国性队列研究
该瑞典全国性队列研究纳入2002-2017年确诊的27,262例乳糜泻患者和132,922例年龄性别匹配的普通人群对照,发现乳糜泻患者后续诊断肠易激综合征的风险显著增加(aHR 3.11,95%CI 2.83-3.42),且乳糜泻与更早的肠易激综合征诊断也相关(OR 3.62,95%CI 3.03-4.34)。
要点
- 乳糜泻患者肠易激综合征风险约为普通人群3倍(aHR 3.11)。
- 随访≥10年后风险仍升高(aHR 2.00,95%CI 1.63-2.45)。
- 乳糜泻与肠易激综合征诊断前关联亦显著(OR 3.62)。
核心结论
- 乳糜泻患者肠易激综合征风险在诊断前后长期升高,临床医生应知晓这一长期关联。
- 与黏膜愈合者相比,随访活检持续绒毛萎缩的乳糜泻患者肠易激综合征诊断风险更低(aHR 0.66,95%CI 0.46-0.95)。
研究设计与样本
- 基于瑞典组织病理学和登记数据的全国性队列研究,纳入2002-2017年确诊的27,262例乳糜泻患者和132,922例年龄性别匹配的普通人群对照。
- 采用Cox回归估计肠易激综合征的风险比(aHR),调整教育水平和Charlson共病指数;次要分析采用条件logistic回归估计比值比(OR)。
主要发现
- 平均随访11.1年,乳糜泻患者732例(2.7%)诊断肠易激综合征,对照1131例(0.9%)。
- 总体(随访≥1年)肠易激综合征aHR为3.11(95%CI 2.83-3.42),随访≥10年aHR为2.00(95%CI 1.63-2.45)。
- 与兄弟姐妹(n=32,010)相比,乳糜泻患者(n=19,211)后续肠易激综合征风险增加≥2倍(aHR 2.42,95%CI 2.08-2.82)。
- 乳糜泻与更早的肠易激综合征诊断相关(OR 3.62,95%CI 3.03-4.34)。
临床怎么用
- 对乳糜泻患者应长期关注肠易激综合征相关症状,诊断前后均需警惕。
- 随访活检持续绒毛萎缩的乳糜泻患者肠易激综合征诊断风险相对较低,可结合黏膜愈合状态评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The aim of this study was to determine the risk of irritable bowel syndrome (IBS) diagnosis in patients with celiac disease (CD) compared with general population comparators. METHODS: Using Swedish histopathology and register-based data, we identified 27,262 patients with CD diagnosed in 2002-2017 and 132,922 age- and sex-matched general population comparators. Diagnoses of IBS were obtained from nationwide inpatient and non-primary outpatient records. Cox regression estimated hazard ratios (aHRs) for IBS adjusted for education level and Charlson Comorbidity Index. To reduce potential surveillance bias our analyses considered incident IBS diagnosis ≥1 year after CD diagnosis. Using conditional logistic regression, secondary analyses were calculated to estimate odds ratios (ORs) for IBS diagnosis ≥1 year before CD diagnosis. RESULTS: During an average of 11.1 years of follow-up, 732 celiac patients (2.7%) were diagnosed with IBS vs 1131 matched general population comparators (0.9%). Overall (≥1-year of follow-up), the aHR for IBS was 3.11 (95% confidence interval [CI], 2.83-3.42), with aHR of 2.00 (95% CI, 1.63-2.45) after ≥10 years of follow-up. Compared with siblings (n = 32,010), celiac patients (n = 19,211) had ≥2-fold risk of later IBS (aHR, 2.42; 95% CI, 2.08-2.82). Compared with celiac patients with mucosal healing, those with persistent villus atrophy on follow-up biopsy were less likely to be diagnosed with IBS (aHR, 0.66; 95% CI, 0.46-0.95). CD was also associated with having an earlier IBS diagnosis (OR, 3.62; 95% CI, 3.03-4.34). CONCLUSIONS: In patients with CD, the risk of IBS is increased long before and after diagnosis. Clinicians should be aware of these long-term associations and their implications on patient management.
引用
- Mårild K, Söderling J, Lebwohl B, et al. Association Between Celiac Disease and Irritable Bowel Syndrome: A Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2024. PMID: 38367742. doi:10.1016/j.cgh.2024.01.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。